Product Launch (Blog)

Jun, 13 2024

Leading Players in Sperm Separation Devices Market: Innovating Fertility Solutions Worldwide

Sperm separation devices are integral tools in assisted reproductive technology (ART), facilitating procedures such as in vitro fertilization (IVF), intrauterine insemination (IUI), and intracytoplasmic sperm injection (ICSI). By isolating high-quality sperm from semen samples based on characteristics such as motility and morphology, these devices enhance the chances of successful fertilization and pregnancy. They employ techniques such as density gradient centrifugation, swim-up methods, or magnetic-activated cell sorting to achieve this. In the ART market, these devices address the critical need for improving fertility outcomes for couples facing reproductive challenges, making them indispensable components of modern reproductive medicine.

The Global Sperm Separation Devices Market valued at USD 593.70 million in 2023 is projected to reach USD 1,987.03 million by 2031, and will grow at a CAGR of 16.3% during the forecast period of 2024-2031.

Below are the Top Sperm Separation Devices Companies with a Significant Market Share:




Product Portfolio

Sales Geographical Coverage



The Cooper Companies Inc

A global medical device company, Cooper specializes in fertility solutions including sperm separation devices. Their portfolio includes innovative technologies for sperm selection and isolation, catering to the needs of assisted reproductive technology (ART) clinics worldwide.

  • PureCeption
  • SupraSperm
  • Sperm Preparation Medium
  • ORIGIO Gradient Series

Europe, Middle East and Africa, Americas, and Asia-Pacific

In August 2022, The Cooper Companies Inc. announced that they had completed the acquisition of Cook Medical’s Reproductive Health business. This has helped the company in improving its international fertility footprint, especially within the Asia-Pacific region.


Bonraybio Co., Ltd.

Bonraybio is a leading provider of sperm separation devices, offering cutting-edge products designed to enhance the efficiency and success rates of ART procedures. Their devices employ advanced techniques such as microfluidics to isolate high-quality sperm for fertilization, contributing significantly to the field of reproductive medicine.

  • Semen Quality Analyzer
  • LensHooke CS0 Semen Test Cassette
  • Liquefaction Test Cup

U.S., Asia, and Europe

In July 2016, Bonraybio Co Ltd. announced that Vivo Capital, a famous venture capital company in Silicon Valley, invested in the company and also offered a lot of resources to develop the market. This has increased the company’s sales and product development.


Menicon Co., Ltd.

Menicon is known for its expertise in vision care products but has also made strides in the development of sperm separation devices for ART applications. Their devices incorporate novel materials and design concepts to optimize sperm selection and improve outcomes in fertility treatments.

  • Sperm Sorter Qualis

Europe, Middle East and Africa, North America, South America, and Asia-Pacific

In December 2020, Menicon Co., Ltd. announced that it had entered into a share purchase agreement with Itabashi Trading Co., Ltd. to make Itabashi a wholly-owned subsidiary of Menicon. This has helped the company import and export medical equipment to China.



Memphasys specializes in developing and commercializing innovative technologies for sperm separation and preparation. Their flagship product, the Felix device, utilizes a unique membrane-based approach to separate sperm based on their characteristics, offering a promising solution for improving IVF success rates.

  • The Felix System
  • Semen Oxidative Stress Diagnostics
  • Felix Media
  • Long Life Media

Australia, North America

In August 2020, Memphasys Ltd announced that with their product development partner, Hydrix Limited, they had been recognized for engineering excellence at the Good Design Awards for the Felix System, a lab instrument for sperm separation. This has increased the company’s value in the market.


SAR Healthline Pvt Ltd.

SAR Healthline is a player in the reproductive health market, offering a range of products, including sperm separation devices. Their devices are designed to meet the specific needs of fertility clinics and laboratories, providing reliable and efficient solutions for sperm selection and preparation in ART procedures.

  • MACS

India, Japan, U.S., Australia, and Germany

In June 2022, SAR Healthline Pvt Ltd. announced that they were attending the exhibit at Embryology Meet-2022 Delhi/Mumbai/Kolkata/Chennai. They introduced their product at the event, which will help the company to increase its sales and customer engagement.


In the sperm separation devices market, companies such as The Cooper Companies Inc., Bonraybio Co., Ltd., Menicon Co., Ltd., Memphasys, and SAR Healthline Pvt Ltd. are pivotal players driving innovation and advancement. Their diverse range of offerings, from cutting-edge technologies to novel approaches in sperm selection and isolation, underscores their commitment to improving fertility outcomes in assisted reproductive technology (ART). With a focus on efficiency, reliability, and efficacy, these companies contribute significantly to addressing the evolving needs of ART clinics and laboratories worldwide, ultimately enhancing the prospects of success for couples seeking fertility treatments.

Client Testimonials